| Hans-Günter Meyer-Thompson | Apotheken
USA. FDA Expands Strategies for Safer Opioid Prescribing
USA. FDA Expands Strategies for Safer Opioid Prescribing
The US Food and Drug Administration (FDA) unveiled a new strategy today that will be added to its broader efforts in addressing the current opioid crisis.
The agency has approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which for the first time requires that all healthcare providers involved in pain management be able to receive voluntary training, and it should not be limited to prescribers. REMS training, therefore, must be made available to nurses and pharmacists. (Medscape, 18.09.2018)